ONCOTHERAPY SCIENCE, INC.

Altre lingue OncoTherapy Science, Inc.

Azioni

4564

JP3202150003

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 25/06/2024			Variaz. 5gg	Var. 1 gen.
34 ^JPY	+6,25%		-2,86%	+47,83%

29/04	Il Primo Ministro polacco Tusk chiama il procuratore per il potenziale scandalo Orlen	RE
2023	OncoTherapy Science, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 marzo 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Triple Negative Breast Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	14/05
Poland's Tusk calls prosecutor over potential Orlen scandal	29/04
OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	22/04
OncoTherapy Science, Inc. announced that it expects to receive ¥3.78 million in funding from Long Corridor Asset Management Limited and another investor	05/04
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 \| Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.	05/12
OncoTherapy Science, Inc.(TSE:4564) dropped from S&P Global BMI Index	18/09/23
OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23
OncoTherapy Science, Inc. announced that it has received ¥95.95 million in funding	10/04/23
OncoTherapy Science, Inc. announced that it expects to receive ¥95.95 million in funding	24/03/23
OncoTherapy Science : Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer	13/09/22
OncoTherapy Science, Inc. announced that it has received ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	28/04/21
OncoTherapy Science, Inc. announced that it expects to receive ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	12/04/21
OncoTherapy Science : Japanese bio-venture starts development of COVID-19 peptide vaccine	01/10/20
OncoTherapy Science, Inc. announced that it has received ¥12.013 million in funding from Daiwa Securities Group Inc.	15/01/19
OncoTherapy Science, Inc. announced that it expects to receive ¥12.013 million in funding from Daiwa Securities Group Inc.	26/12/18
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company	14/07/17
OncoTherapy Science, Inc.(TSE:4564) added to Russell Global Index	29/06/15
OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A	31/07/13
Shionogi & Co. Signs Agreement with OncoTherapy Science Inc. for Cancer Peptide Vaccines	02/04/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

I nostri contenuti gratuiti ti aiutano a mettere al sicuro e ad aumentare la performance dei tuoi investimenti

Assicurare i miei Investimenti

fermer